A client receiving vancomycin IV develops redness and pain at the IV site. What is the most appropriate corrective action?

A client receiving vancomycin IV develops redness and pain at the IV site. What is the most appropriate corrective action?

• A. Slow the rate of infusion.
• B. Change the site of the infusion.
• C. Notify the physician.
• D. Stop the infusion for at least 24 hours.

Answer: (B)

Redness and pain at the IV site during vancomycin infusion signal irritation of the vein, or phlebitis, from the IV line. The priority is to protect the vein and prevent tissue damage, so move the infusion to a new IV site and start the infusion there after removing the cannula from the irritated site. This immediate action minimizes ongoing vein irritation and reduces the risk of complications from continuing to use a damaged site. Slowing the rate might help with broader systemic reactions but does not address the local vein irritation. Stopping the infusion for a long period or delaying treatment isn’t appropriate when a local IV site reaction is present. If symptoms persist or worsen, notify the physician for further guidance, but relocation of the IV site is the correct first step.

Redness and pain at the IV site during vancomycin infusion signal irritation of the vein, or phlebitis, from the IV line. The priority is to protect the vein and prevent tissue damage, so move the infusion to a new IV site and start the infusion there after removing the cannula from the irritated site. This immediate action minimizes ongoing vein irritation and reduces the risk of complications from continuing to use a damaged site. Slowing the rate might help with broader systemic reactions but does not address the local vein irritation. Stopping the infusion for a long period or delaying treatment isn’t appropriate when a local IV site reaction is present. If symptoms persist or worsen, notify the physician for further guidance, but relocation of the IV site is the correct first step.